AngioDynamics Valuation
| ANGO Stock | USD 9.40 0.04 0.42% |
At this time, the firm appears to be undervalued. AngioDynamics shows a prevailing Real Value of $11.37 per share. The current price of the firm is $9.4. Our model approximates the value of AngioDynamics from analyzing the firm fundamentals such as return on equity of -0.76, and Profit Margin of (0.78) % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting AngioDynamics' valuation include:
Price Book 2.0453 | Enterprise Value | Enterprise Value Ebitda (137.63) | Price Sales 1.3333 | Forward PE 96.1538 |
Undervalued
Today
Please note that AngioDynamics' price fluctuation is slightly risky at this time. Calculation of the real value of AngioDynamics is based on 3 months time horizon. Increasing AngioDynamics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since AngioDynamics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of AngioDynamics Stock. However, AngioDynamics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 9.4 | Real 11.37 | Target 15.33 | Hype 9.41 | Naive 8.89 |
The intrinsic value of AngioDynamics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence AngioDynamics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of AngioDynamics helps investors to forecast how AngioDynamics stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of AngioDynamics more accurately as focusing exclusively on AngioDynamics' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use AngioDynamics' intrinsic value based on its ongoing forecasts of AngioDynamics' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against AngioDynamics' closest peers.
AngioDynamics Cash |
|
AngioDynamics Valuation Trend
Knowing AngioDynamics' actual value is paramount for traders when making sound investment determinations. Using both AngioDynamics' enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
AngioDynamics Revenue by Product
AngioDynamics Total Value Analysis
AngioDynamics is presently forecasted to have valuation of 332.87 M with market capitalization of 382 M, debt of 5.91 M, and cash on hands of 24.56 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the AngioDynamics fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
332.87 M | 382 M | 5.91 M | 24.56 M |
AngioDynamics Investor Information
About 85.0% of the company shares are held by institutions such as insurance companies. The book value of AngioDynamics was presently reported as 4.57. The company has Price/Earnings To Growth (PEG) ratio of 1.87. AngioDynamics recorded a loss per share of 5.59. The entity had not issued any dividends in recent years. Based on the key indicators related to AngioDynamics' liquidity, profitability, solvency, and operating efficiency, AngioDynamics is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.AngioDynamics Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. AngioDynamics has an asset utilization ratio of 95.67 percent. This suggests that the Company is making $0.96 for each dollar of assets. An increasing asset utilization means that AngioDynamics is more efficient with each dollar of assets it utilizes for everyday operations.AngioDynamics Ownership Allocation
AngioDynamics holds a total of 40.47 Million outstanding shares. The majority of AngioDynamics outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in AngioDynamics to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in AngioDynamics. Please pay attention to any change in the institutional holdings of AngioDynamics as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.AngioDynamics Profitability Analysis
The company reported the previous year's revenue of 303.91 M. Net Loss for the year was (184.35 M) with profit before overhead, payroll, taxes, and interest of 151.01 M.About AngioDynamics Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of AngioDynamics. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of AngioDynamics based exclusively on its fundamental and basic technical indicators. By analyzing AngioDynamics's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of AngioDynamics's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of AngioDynamics. We calculate exposure to AngioDynamics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of AngioDynamics's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 177.9 M | 131.3 M | |
| Pretax Profit Margin | (0.73) | (0.69) | |
| Operating Profit Margin | (0.73) | (0.69) | |
| Net Loss | (0.70) | (0.66) | |
| Gross Profit Margin | 0.51 | 0.59 |
AngioDynamics Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 40.2 M | |
| Forward Price Earnings | 96.1538 |
AngioDynamics Current Valuation Indicators
AngioDynamics' valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final AngioDynamics' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as AngioDynamics, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use AngioDynamics' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes AngioDynamics' worth.When determining whether AngioDynamics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AngioDynamics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Angiodynamics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Angiodynamics Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AngioDynamics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AngioDynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.59) | Revenue Per Share | Quarterly Revenue Growth (0.08) | Return On Assets | Return On Equity |
The market value of AngioDynamics is measured differently than its book value, which is the value of AngioDynamics that is recorded on the company's balance sheet. Investors also form their own opinion of AngioDynamics' value that differs from its market value or its book value, called intrinsic value, which is AngioDynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AngioDynamics' market value can be influenced by many factors that don't directly affect AngioDynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AngioDynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AngioDynamics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioDynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.